SCHEMBL4642301

SCHEMBL4642301

CCOC(=O)Oc1cccc2c1ncn2CCC(C)(C)NCC(O)c1cccc(NS(=O)(=O)c2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 12/20 0.41
ADRB2 P07550 2/20 0.38
ADRB1 P08588 2/20 0.38
ALDH1A1 P00352 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HPGD P15428 1/20 0.33
F2 P00734 1/20 0.33
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4642274 0.99 ADRB3 (0.41) ADRB3ADRB2ADRB1ALDH1A1NPSR1
SCHEMBL4908096 0.89 ADRB3 (0.42) ADRB3ADRB2ADRB1ALDH1A1NPSR1
Hydrochloric Acid SCHEMBL4916184 0.88 ADRB3 (0.41) ADRB3ADRB2ADRB1ALDH1A1NPSR1
SCHEMBL4832542 0.88 ADRB3 (0.40) ADRB3ADRB2ADRB1ALDH1A1NPSR1
SCHEMBL4645453 0.87 ADRB3 (0.45) ADRB3ADRB2ADRB1ALDH1A1NPSR1
SCHEMBL4643457 0.87 ADRB3 (0.47) ADRB3ALDH1A1OPRM1OPRD1LMNA
SCHEMBL4640303 0.87 ADRB3 (0.47) ADRB3ALDH1A1OPRM1OPRD1LMNA
SCHEMBL4640763 0.87 ADRB3 (0.45) ADRB3ADRB2ADRB1ALDH1A1NPSR1
SCHEMBL4840747 0.86 ADRB3 (0.42) ADRB3ADRB2ADRB1ALDH1A1NPSR1
SCHEMBL4777081 0.86 ADRB3 (0.42) ADRB3ADRB2ADRB1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943229-A1 BENZIMIDAZOLE DERIVATIVES FOR USE AS BETA-3 RECEPTOR AGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-07-16 EP disclosed
WO-2007048842-A1 BENZIMIDAZOLE DERIVATIVES FOR USE AS BETA-3 RECEPTOR AGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-05-03 WO disclosed